Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19

Low-dose corticosteroid combined with immunoglobulin reverses deterioration in severe cases with COVID-19

Bibliographic Details
Main Authors:	Zhi-Guo Zhou, Di-Xuan Jiang, Shu-Min Xie, Jing Zhang, Fang Zheng, Hong Peng, Xuan Chen, Ji-Yang Liu, Lei Zhang
Format:	Article
Language:	English
Published:	Nature Publishing Group 2020-11-01
Series:	Signal Transduction and Targeted Therapy
Online Access:	https://doi.org/10.1038/s41392-020-00407-0

Similar Items

Severe pneumonia in mycophenolate mofetil combined with low-dose corticosteroids-treated patients with immunoglobulin A nephropathy
by: Qi-Jun Wan, et al.
Published: (2015-01-01)

Clinical Efficacy of Corticosteroids in the Early Stages of Deterioration in COVID-19 Pneumonia
by: Liu Z, et al.
Published: (2021-07-01)

Treatment of allopurinol-induced toxic epidermal necrolysis with high dose corticosteroids and intravenous immunoglobulins
by: Mehmet Akyürek, et al.
Published: (2019-07-01)

A Case of Toxic Epidermal Necrolysis Successfully Treated with Low Dose Intravenous Immunoglobulins and Systemic Corticosteroid
by: Lutfi Al-Kathiri, et al.
Published: (2018-07-01)

Using biomarkers to adjust corticosteroid dose in patients with severe asthma
by: Thomas L. Jones
Published: (2021-03-01)

Clinical Use of Short-Course and Low-Dose Corticosteroids in Patients With Non-severe COVID-19 During Pneumonia Progression
by: Zhiliang Hu, et al.
Published: (2020-07-01)

Posterior Reversible Encephalopathy Syndrome due to High Dose Corticosteroids for an MS Relapse
by: Sarah A. Morrow, et al.
Published: (2015-01-01)

Corticosteroid insensitivity in severe asthma
by: Hew, Mark Ji-Liang
Published: (2007)

Successful intravenous immunoglobulin treatment in severe COVID-19 pneumonia
by: Maurizia Lanza, et al.
Published: (2020-01-01)

Use of Corticosteroid in Children with Unresponsiveness to Intravenous Immunoglobulin in Kawasaki Disease
by: Abdolkarim Hamedi, et al.
Published: (2017-08-01)

Corticosteroids and Intravenous Immunoglobulin in Pediatric Myocarditis: A Meta-Analysis
by: Yining Li, et al.
Published: (2019-08-01)

Corticosteroids in severe COVID-19: a critical view of the evidence
by: Daniel De Backer, et al.
Published: (2020-10-01)

High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis
by: Cherin Patrick, et al.
Published: (2014-01-01)

Corrigendum to “High-Dose Subcutaneous Immunoglobulins for the Treatment of Severe Treatment-Resistant Polymyositis”
by: Patrick Cherin, et al.
Published: (2015-01-01)

Judicious use of low-dosage corticosteroids for non-severe COVID-19: A case report
by: Zhang Jian, et al.
Published: (2021-03-01)

Prognostic value of lymphocyte count in severe COVID-19 patients with corticosteroid treatment
by: Chenyang Lu, et al.
Published: (2021-03-01)

"High Doses Intravenous Immunoglobulin versus Oral Cyclosporine in the Treatment of Severe Atopic Dermatitis "
by: "Mohammad Hassan Bemanian, et al.
Published: (2005-09-01)

Intravenous immunoglobulin for severe protracted pediatric Guillain–Barre syndrome: Is single dose adequate?
by: Priyanka Madaan, et al.
Published: (2019-01-01)

High‐dose, short‐term corticosteroids for ARDS caused by COVID‐19: a case series
by: Clara So, et al.
Published: (2020-08-01)

Oral dosing for antenatal corticosteroids in the Rhesus macaque.
by: Augusto F Schmidt, et al.
Published: (2019-01-01)

Efficacy Evaluation of Early, Low-Dose, Short-Term Corticosteroids in Adults Hospitalized with Non-Severe COVID-19 Pneumonia: A Retrospective Cohort Study
by: Qiang Li, et al.
Published: (2020-09-01)

High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
by: Wei Cao, et al.
Published: (2021-02-01)

Endogenous fungal endophthalmitis following intensive corticosteroid therapy in severe COVID-19 disease
by: Daraius Shroff, et al.
Published: (2021-01-01)

Eosinophilic granulomatosis with polyangiitis: myocardial thickening reversed by corticosteroids
by: Gustav Mattsson, et al.
Published: (2017-12-01)

Restoration of corticosteroid sensitivity in severe asthma
by: Mercado, Nicolas
Published: (2008)

High doses of immunoglobulin g in the therapy for severe forms of myasthenia gravis and Guillain-Barré syndrome
by: Lavrnić Dragana, et al.
Published: (2006-01-01)

Intravenous immunoglobulin-based adjuvant therapy for severe COVID-19: a single-center retrospective cohort study
by: Xiao Hou, et al.
Published: (2021-05-01)

Distinct kinetics of immunoglobulin isotypes reveal early diagnosis and disease severity of COVID‐19: A 6‐month follow‐up
by: Siyang Yu, et al.
Published: (2021-03-01)

Reversing Autoimmunity Combination of Rituximab and Intravenous Immunoglobulin
by: A. Razzaque Ahmed, et al.
Published: (2018-07-01)

The Effect of Intravenous Immunoglobulin Combined with Corticosteroid on the Progression of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Meta-Analysis.
by: Liang-Ping Ye, et al.
Published: (2016-01-01)

Valproate-Induced Reversible Brain Atrophy and Cognitive Deterioration
by: J Gordon Millichap, et al.
Published: (2014-09-01)

Reversal deterioration of renal function accompanied with primary hypothyrodism
by: Dragović Tamara
Published: (2012-01-01)

Cost-utility of Intravenous Immunoglobulin (IVIG) compared with corticosteroids for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) in Canada
by: Campbell Kaitryn, et al.
Published: (2010-06-01)

Corrigendum: High-Dose Intravenous Immunoglobulin in Severe Coronavirus Disease 2019: A Multicenter Retrospective Study in China
by: Wei Cao, et al.
Published: (2021-03-01)

Assessment of high-dose inhalational corticosteroids vs systemic corticosteroids in acute exacerbations of COPD in diabetic patients
by: A. S. Magdy, et al.
Published: (2020-01-01)

Perioperative “stress dose” of corticosteroid: Pharmacological and clinical perspective
by: Geetanjali T Chilkoti, et al.
Published: (2019-01-01)

Corticosteroids and rehabilitation in COVID-19 survivors
by: Amos Lal, et al.
Published: (2021-05-01)

Corticosteróides e a COVID-19
by: Diogo Paulo Duarte Gonçalves
Published: (2021)

Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
by: Qingqing Cai, et al.
Published: (2017-07-01)

High-Dose Intravenous Immunoglobulins in the Treatment of Severe Acute Viral Pneumonia: The Known Mechanisms and Clinical Effects
by: Xiaosheng Liu, et al.
Published: (2020-07-01)

Cannot write session to /tmp/vufind_sessions/sess_sncukrusgkbhajhn6p7so8ko3j